Assessment of the statistical significance of classifications in infrared spectroscopy based diagnostic models
Autors de IIS La Fe
Autors aliens a IIS La Fe
- Pérez-Guaita D
- Garrigues S
- Wood BR
Grups d'Investigació
Abstract
Fourier transform infrared (IR) spectroscopy in combination with multivariate data analysis is a versatile tool that can be applied to disease diagnosis. However, a rigorous validation of the obtained models is necessary in order to obtain robust results. This work evaluates the advantages of the use of permutation testing for determining the statistical significance of the misclassification errors obtained from IR based diagnostic models through cross validation (CV). The model performance, estimated by CV, is compared to a distribution of CV-performance values obtained using randomly permuted class labels. The distribution of 'random CV-values' is considered as a null distribution and used to establish the significance of the model estimators obtained using real class labels. ATR-FTIR spectra of serum samples were classified using random forest (RF) classifiers according to two criteria, the tag number (a randomly assigned pseudo class membership) and the level of urea (real class). CV errors obtained were compared to the null distribution of CV errors from a permutation test and an independent validation set. The procedure was evaluated testing typical conditions leading to overoptimistic estimations provided by the CV like e.g. the size of subsamples used during CV, variable selection and the use of replicates. Results show that for the tag number (pseudo class), CV indicated classification errors between 23 and 33% depending on the subsample size employed. Those values were even lower when variable selection or replicates were used. However, permutation testing indicated that those CV errors were non-significant. In contrast, for sample classification according to their levels of urea, all cross validation errors were found to be significant. Although the proposed method is computationally intensive, it provides a simple way of calculating an empirical p-value of the CV-estimator, thus establishing the statistical significance and providing a feasibility indicator especially useful for studies where the number of samples is limited.
Dades de la publicació
- ISSN/ISSNe:
- 0003-2654, 1364-5528
- Tipus:
- Article
- Pàgines:
- 2422-2427
- DOI:
- 10.1039/c4an01783h
- PubMed:
- 25382314
- Factor d'Impacte:
- 1,229 SCImago ℠
- Quartil:
- Q1 SCImago ℠
ANALYST ROYAL SOC CHEMISTRY
Cites Rebudes en Web of Science: 18
Documents
- No hi ha documents
Filiacions
Keywords
- CHANCE CORRELATION; SERUM; VALIDATION; TOOL
Projectes associats
UTILIDAD DEL TRATAMIENTO TOCOLITICO DE MANTENIMIENTO EN EL MANEJO DE LA AMENAZA DE PARTO PREMATURO (APP)
Investigador Principal: MÁXIMO VENTO TORRES
EC11-246 . 2012
MULTICENTER, RANDOMIZED, BLINDED CLINICAL STUDY COMPARING EARLY USE OF TOTAL BODY MODERATE HYPOTHERMIA PLUS TOPIRAMATE OR PLACEBO IN ASPHYXIATED NEWBORN INFANTS EVOLVING TO MODERATE-TO-SEVERE HYPOXIC ISCHEMIC ENCEPHALOPATHY
Investigador Principal: MÁXIMO VENTO TORRES
EC11-244 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2012
EFECTO DE LA MODULACION DEL FACTOR INDUCIBLE POR HIPOXIA (HIF) SOBRE LA DEGENERACION RETINIANA EN RETINOSIS PIGMENTARIA
Investigador Principal: REGINA RODRIGO NICOLÁS
PI12/00481 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2013
RED DE SALUD MATERNO INFANTIL Y DEL DESARROLLO
Investigador Principal: MÁXIMO VENTO TORRES
RD12/0026/0012 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2013
CONTRATO POSTDOCTORAL DE INVESTIGACION SARA BORELL
CD12/00667 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2013
DAÑO OXIDATIVO Y METILACIÓN DEL ADN Y ACTIVIDAD DE LAS ENZIMAS REPARADORAS Y SU FRECUENCIA MUTAGÉNICA EN PREMATUROS SEGÚN LA CARGA DE OXÍGENO RECIBIDA EN LA REANIMACIÓN
Investigador Principal: MÁXIMO VENTO TORRES
PI14/00443 . INSTITUTO DE SALUD CARLOS III . 2015
IMPACTO DEL ECMO SOBRE LA FARMACOCINÉTICA DE LA ANIDULAFUNGINA.
Investigador Principal: FRANCISCA PÉREZ ESTEBAN
PFI-ANI-2013-01